These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30616520)

  • 1. Interaction between TP53 and XRCC1 increases susceptibility to cervical cancer development: a case control study.
    Liu GC; Zhou YF; Su XC; Zhang J
    BMC Cancer; 2019 Jan; 19(1):24. PubMed ID: 30616520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of polymorphic markers Arg399Gln of XRCC1 gene, Arg72Pro of TP53 gene and T309G of MDM2 gene with breast cancer in Kyrgyz females.
    Isakova J; Talaibekova E; Aldasheva N; Vinnikov D; Aldashev A
    BMC Cancer; 2017 Nov; 17(1):758. PubMed ID: 29132330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of DNA Repair Genes XRCC1 and APE-1 with the Risk of Cervical Cancer in North Indian population.
    Charles MR; Raza ST; Sharma R; Pratap P; Eba A; Singh M
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):2061-2065. PubMed ID: 32711433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Polymorphism in Base Excision Repair and Nucleotide Excision Repair Genes and Risk of Cervical Cancer: A Case-Control Study.
    Datkhile KD; Durgawale PP; Patil MN; Gudur RA; Gudur AK; Patil SR
    Asian Pac J Cancer Prev; 2022 Apr; 23(4):1291-1300. PubMed ID: 35485688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haplotype analysis of XRCC1 gene polymorphisms and the risk of thyroid carcinoma.
    Bashir K; Sarwar R; Fatima S; Saeed S; Mahjabeen I; Akhtar Kayani M
    J BUON; 2018; 23(1):234-243. PubMed ID: 29552790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Predisposition to Cervical Cancer and the Association With XRCC1 and TGFB1 Polymorphisms.
    Al-Harbi NM; Bin Judia SS; Mishra KN; Shoukri MM; Alsbeih GA
    Int J Gynecol Cancer; 2017 Nov; 27(9):1949-1956. PubMed ID: 28906311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidation of Increased Cervical Cancer Risk Due to Polymorphisms in XRCC1 (R399Q and R194W), ERCC5 (D1104H), and NQO1 (P187S).
    Das AP; Saini S; Tyagi S; Chaudhary N; Agarwal SM
    Reprod Sci; 2023 Apr; 30(4):1118-1132. PubMed ID: 36195778
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Cavic M; Spasic J; Krivokuca A; Boljevic I; Kuburovic M; Radosavljevic D; Jankovic R
    J Clin Pathol; 2019 Jan; 72(1):75-80. PubMed ID: 30467244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between XRCC1 polymorphisms and the risk of cervical cancer: a meta-analysis based on 4895 subjects.
    Zeng X; Zhang Y; Yue T; Zhang T; Wang J; Xue Y; An R
    Oncotarget; 2017 Jan; 8(2):2249-2260. PubMed ID: 27903984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms in DNA repair genes and their association with cervical cancer.
    Abbas M; Srivastava K; Imran M; Banerjee M
    Br J Biomed Sci; 2019 Jul; 76(3):117-121. PubMed ID: 30870085
    [No Abstract]   [Full Text] [Related]  

  • 11. Polymorphisms in XRCC1, ERCC2, and ERCC3 DNA repair genes, CYP1A1 xenobiotic metabolism gene, and tobacco are associated with bladder cancer susceptibility in Tunisian population.
    Feki-Tounsi M; Khlifi R; Louati I; Fourati M; Mhiri MN; Hamza-Chaffai A; Rebai A
    Environ Sci Pollut Res Int; 2017 Oct; 24(28):22476-22484. PubMed ID: 28803404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Male and female breast cancer: the two faces of the same genetic susceptibility coin.
    Silva SN; Gomes BC; André S; Félix A; Rodrigues AS; Rueff J
    Breast Cancer Res Treat; 2021 Jul; 188(1):295-305. PubMed ID: 33942220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in HPV E6/E7 protein interacted genes and risk of cervical cancer in Chinese women: a case-control analysis.
    Zhou X; Han S; Wang S; Chen X; Dong J; Shi X; Xia Y; Wang X; Hu Z; Shen H
    Gynecol Oncol; 2009 Aug; 114(2):327-31. PubMed ID: 19482343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in cancer susceptibility genes XRCC1, RAD51 and TP53 and the risk of breast cancer in Serbian women.
    Krivokuca AM; Cavic MR; Malisic EJ; Rakobradovic JD; Kolarevic-Ivankovic D; Tomasevic ZI; Brankovic-Magic MV
    Int J Biol Markers; 2016 Jul; 31(3):e258-63. PubMed ID: 26954070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between X-Ray Repair Cross-Complementing Group 1 Arg399Gln Polymorphism and Cervical Cancer Risk: A Meta-Analysis in the Chinese Population.
    Zhang F; Li B; Wu HY; Shang LX
    Gynecol Obstet Invest; 2017; 82(4):382-387. PubMed ID: 27487002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TP53 genetic polymorphisms and susceptibility to cervical cancer in Bangladeshi women: a case-control study.
    Apu MNH; Rashed AZM; Bashar T; Rahman MM; Mostaid MS
    Mol Biol Rep; 2020 Jun; 47(6):4357-4364. PubMed ID: 32424519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of the XRCC1 Arg399Gln gene polymorphism in the development of cervical carcinoma.
    Roszak A; Lianeri M; Jagodzinski PP
    Int J Biol Markers; 2011; 26(4):216-20. PubMed ID: 21928248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of TP53 codon 72 polymorphism with cervical cancer risk in Chinese women.
    Jiang P; Liu J; Zeng X; Li W; Tang J
    Cancer Genet Cytogenet; 2010 Mar; 197(2):174-8. PubMed ID: 20193851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between mutation of p53 gene 2-4 exons from peripheral blood and HPV16 positive cervical cancer susceptibility and clinical significance].
    Yin CM; Yao YF; Yan ZL; Yang HY
    Zhonghua Fu Chan Ke Za Zhi; 2017 May; 52(5):320-326. PubMed ID: 28545270
    [No Abstract]   [Full Text] [Related]  

  • 20. DNA base excision repair genes variants rs25487 (X-ray repair cross-complementing 1) and rs1052133 (human 8-oxoguanine glycosylase 1) with susceptibility to ovarian cancer in the population of the Jammu region, India.
    Verma S; Sharma V; Nagpal A; Bhat A; Bhat GR; Shah R; Wakhloo A; Suri J; Abrol D; Kaul S; Bhat A; Verma V; Kumar R
    J Cancer Res Ther; 2019; 15(6):1270-1275. PubMed ID: 31898659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.